Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion.
Urol Oncol. 2017 Aug 03;:
Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort.
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):41-46
J Natl Cancer Inst. 2017 Apr 01;109(4):
Ophthalmic Genet. 2017 Jan 13;:1-3
Development and External Validation of a Biopsy-Derived Nomogram to Predict Risk of Ipsilateral Extraprostatic Extension.
BJU Int. 2016 Dec 08;:
Congenital limb deficiencies with vascular etiology: Possible association with maternal thrombophilia.
Am J Med Genet A. 2016 Aug 17;
Limitations in predicting organ-confined prostate cancer in patients with Gleason pattern 4 on biopsy: Implications for active surveillance.
J Urol. 2016 Jul 22;
Brain Dev. 2016 Jul 9;
The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.
Elife. 2016 Apr 29;5
J Ultrasound Med. 2015 Dec 3;